US 11845726
C4-carbonothioate-substituted tryptamine derivatives and methods of using
granted A61KA61K31/4045A61P
Quick answer
US patent 11845726 (C4-carbonothioate-substituted tryptamine derivatives and methods of using) held by Enveric Biosciences Canada Inc. expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enveric Biosciences Canada Inc.
- Grant date
- Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/4045, A61P, A61P25/00